Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris

PHASE4CompletedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

March 31, 2002

Study Completion Date

August 31, 2002

Conditions
Acne Vulgaris
Interventions
DRUG

Tazarotene 0.1% gel + placebo capsule, Oral minocycline (100 mg capsule) + vehicle gel, Tazarotene 0.1% gel + oral minocycline (100 mg capsule)

Trial Locations (1)

19008

KGL, Inc, Broomall

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Milton S. Hershey Medical Center

OTHER

collaborator

State University of New York - Downstate Medical Center

OTHER

collaborator

Jefferson Medical College of Thomas Jefferson University

OTHER

collaborator

NYU Langone Health

OTHER

collaborator

Allergan

INDUSTRY

lead

KGL, Inc.

OTHER